If you liked this article you might like

Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO
Biotech Premarket Movers: Insys, Ultragenyx, Alexion
Alexion Pharmaceuticals Cuts 7% of Workforce
Celgene's Deep Pipeline Can Reassure Investors